Cargando…

Nanozymes in Tumor Theranostics

Nanozymes, a new generation of enzyme mimics, have recently attracted great attention. Nanozymes could catalyze chemical reactions as biological enzymes under physiologically mild conditions with higher-efficiency catalytic activities. Moreover, nanozymes could overcome the shortcomings of natural e...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Qiulian, Liu, Yanfang, Zhu, Haitao, Zhang, Lirong, Liao, Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560966/
https://www.ncbi.nlm.nih.gov/pubmed/34737942
http://dx.doi.org/10.3389/fonc.2021.666017
_version_ 1784593033401991168
author Ma, Qiulian
Liu, Yanfang
Zhu, Haitao
Zhang, Lirong
Liao, Xiang
author_facet Ma, Qiulian
Liu, Yanfang
Zhu, Haitao
Zhang, Lirong
Liao, Xiang
author_sort Ma, Qiulian
collection PubMed
description Nanozymes, a new generation of enzyme mimics, have recently attracted great attention. Nanozymes could catalyze chemical reactions as biological enzymes under physiologically mild conditions with higher-efficiency catalytic activities. Moreover, nanozymes could overcome the shortcomings of natural enzymes, such as easy inactivation, high cost, and low yield. With the development of more and more smart and multi-functional nanosystems, nanozymes display great achievement in tumor biology. In this review, we outline the recent advances of nanozymes in tumor and tumor microenvironment diagnosis, therapy, and theranostics.
format Online
Article
Text
id pubmed-8560966
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85609662021-11-03 Nanozymes in Tumor Theranostics Ma, Qiulian Liu, Yanfang Zhu, Haitao Zhang, Lirong Liao, Xiang Front Oncol Oncology Nanozymes, a new generation of enzyme mimics, have recently attracted great attention. Nanozymes could catalyze chemical reactions as biological enzymes under physiologically mild conditions with higher-efficiency catalytic activities. Moreover, nanozymes could overcome the shortcomings of natural enzymes, such as easy inactivation, high cost, and low yield. With the development of more and more smart and multi-functional nanosystems, nanozymes display great achievement in tumor biology. In this review, we outline the recent advances of nanozymes in tumor and tumor microenvironment diagnosis, therapy, and theranostics. Frontiers Media S.A. 2021-10-19 /pmc/articles/PMC8560966/ /pubmed/34737942 http://dx.doi.org/10.3389/fonc.2021.666017 Text en Copyright © 2021 Ma, Liu, Zhu, Zhang and Liao https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Ma, Qiulian
Liu, Yanfang
Zhu, Haitao
Zhang, Lirong
Liao, Xiang
Nanozymes in Tumor Theranostics
title Nanozymes in Tumor Theranostics
title_full Nanozymes in Tumor Theranostics
title_fullStr Nanozymes in Tumor Theranostics
title_full_unstemmed Nanozymes in Tumor Theranostics
title_short Nanozymes in Tumor Theranostics
title_sort nanozymes in tumor theranostics
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560966/
https://www.ncbi.nlm.nih.gov/pubmed/34737942
http://dx.doi.org/10.3389/fonc.2021.666017
work_keys_str_mv AT maqiulian nanozymesintumortheranostics
AT liuyanfang nanozymesintumortheranostics
AT zhuhaitao nanozymesintumortheranostics
AT zhanglirong nanozymesintumortheranostics
AT liaoxiang nanozymesintumortheranostics